Litcius/Paper detail

Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open-label randomized trial (ASPREO)

Farah H. Amro, Sean C. Blackwell, Claudia Pedroza, Sami Backley, Ghamar Bitar, Nahla Daye, Michal Fishel Bartal, Suneet P. Chauhan, Baha M. Sibai

2024American Journal of Obstetrics and Gynecology13 citationsDOI

Topics & Concepts

MedicineAspirinPreeclampsiaOpen labelRandomized controlled trialInternal medicinePregnancyObstetricsBiologyGeneticsPregnancy and preeclampsia studiesGestational Diabetes Research and ManagementCardiovascular Issues in Pregnancy
Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open-label randomized trial (ASPREO) | Litcius